Company intelligence / Profile preview
Artelo Biosciences
Solana Beach, California, United Statesartelobio.com ↗
- Ownership
- Public · ARTLW
- Development stage
- Other
01
Overview
Artelo has three main clinical programs. ART26.12, a first-in-class selective FABP5 inhibitor for painful neuropathies, completed its first cohort in a Phase I trial with further results expected in mid–2025. ART27.13, originally developed by AstraZeneca, showed statistically significant weight gain in prior studies and is now in a Phase II trial for cancer-related anorexia/cachexia syndrome. ART12.11, a proprietary cannabidiol cocrystal composition with improved pharmacokinetics over standard CBD formulations, has shown promising nonclinical results; human studies are planned for late–2025.[3][6][8] No commercial products yet.
- Therapeutic areas
- OncologyEndocrinologyNeurologyRheumatology
- Modalities
- Small molecules (including cocrystals and selective inhibitors)[3][8]
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
03
Partnerships
Worldwide Clinical Trials CRO partner for clinical trials of ART26.12 [9]
Beyond the preview
Go deeper on Artelo Biosciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Artelo Biosciences.